Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV)’s share price traded up 5.9% during trading on Wednesday . The company traded as high as $3.34 and last traded at $3.25, with a volume of 664,407 shares traded. The stock had previously closed at $3.07.

A number of equities analysts have recently commented on the company. Zacks Investment Research raised Kitov Pharmaceuticals Holdings from a “hold” rating to a “buy” rating and set a $3.25 price target for the company in a report on Wednesday, July 13th. Rodman & Renshaw reaffirmed a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a report on Monday, July 11th.

The company’s market capitalization is $12.10 million. The company has a 50-day moving average price of $3.25 and a 200-day moving average price of $3.94.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.